Enavate Sciences GP, LLC
ENAVATE SCIENCES GP, LLC is a New York-based investment firm specializing in providing growth capital and strategic support to innovative companies in the biotechnology and therapeutic sectors. The firm focuses primarily on investments in biopharmaceutical and therapeutic companies at both pre-clinical and clinical stages, particularly those with high growth potential and addressing unmet medical needs. ENAVATE strives to be a partner of choice for life sciences companies and their existing investors, offering not only significant capital but also personalized, hands-on guidance to help portfolio companies realize their full potential. Founded in 2022, ENAVATE serves institutional investors and works closely with growth-stage healthcare companies.
Investment Strategy
ENAVATE SCIENCES GP, LLC employs a focused, hands-on investment strategy targeting biopharmaceutical and therapeutic companies across a broad range of therapeutic areas. The firm's approach emphasizes supporting innovative, high-potential enterprises at pre-clinical and clinical stages—prioritizing opportunities that address significant unmet medical needs and have a strong potential for transformative impact on patient care. ENAVATE provides not only significant financial capital but also strategic operational support, partnerships, and company-building expertise. Their strategy is rooted in close collaboration with management teams, scientific founders, and co-investors to accelerate clinical, regulatory, and commercial inflection points and to maximize long-term growth and value creation.
Top Holdings
Equity Positions (6)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
I IMNM | IMMUNOME INC | 25.12% | $44.3M | 4,768,583 | $9.57 | $9.30 | +$12.3M |
S SION | SIONNA THERAPEUTICS INC | 24.35% | $43.0M | 2,478,030 | $10.46 | $17.35 | +$17.1M |
Z ZBIO | ZENAS BIOPHARMA INC | 20.65% | $36.4M | 3,761,359 | $8.19 | $9.69 | +$6.7M |
U UPB | UPSTREAM BIO INC | 15.30% | $27.0M | 2,459,703 | $16.44 | $10.98 | +$12.0M |
C CMPX | COMPASS THERAPEUTICS INC | 11.47% | $20.2M | 7,788,150 | $1.45 | $2.60 | +$5.5M |